Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology
Shiran Su(National Institutes of Health), David L. Brody(Uniformed Services University of the Health Sciences)
Cited by 16
Related Papers
Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel
|New England Journal of Medicine|2011|596
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
|Neurology|2021|322
Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
|Scientific Reports|2017|165
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
|Scientific Reports|2020|123
Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method
|International Journal of Molecular Sciences|2021|15